
Public equities/options, card product @mercury. Eternal superalloy cubes @ https://nitter.gq/t.co/fz34u7r194.
North America
Joined April 2014
- Tweets2.2K
- Following500
- Followers1.7K
- Likes22.8K
John Mason retweeted
Top-notch communication from both today. My assumptions:
1) Ex-FDA GI division reviewers writing/reviewing NDA content. NDA submission in Nov.
2) Looking at Oral combo only. Their own oral α4β7 or IL-23 combo with Obe may be announced in Jan with some cheap Chinese partner. This move makes Gilead, Lilly and J&J oral pipeline and combination redundant. They need to act fast.
3) CD- Can see blinded data from blinded arms. Can see arm 1 (placebo) bad, arm 2 slightly better (12.5 mg) and arm 3 (25 mg) and 4 (50 mg) exceedingly doing well compared to 1 and 2. Not much difference in 2 and 3. That gives confidence in CD.
4) Final CD induction enrollment announcement in Dec. March last 12 week visit. April - May data.
4) They are reading BioX.
John Mason retweeted
Transaction volume on virtual cards for AI agents may be small for now, but offering the cards positions Mercury as the bank of the future. f-st.co/LsP5rYr
John Mason retweeted
Replying to @anuroopk4u @pmarca
Since the 1970s, many people who wanted housing to be more affordable supported rules that made it harder to build. The result was less housing, more scarcity, and higher prices. We made housing unaffordable in the name of affordability.
John Mason retweeted
I got fired today from my side gig at Slack
I was the PM responsible for the new activity feed
John Mason retweeted
I said to a friend once when he was shutting down his startup that the thing i like most about tech is that you’re always just 6 months of really good work away from turning everything around.
Have seen it happen several times — to people who felt like their careers had been swept up from under them, including, as it happens, that particular friend.
John Mason retweeted
Mike Davis, the new acting CDER head, was the guy Vinay Prasad threatened to "spend all of my political capital to get you fired"
The irony that Vinay Prasad will be known as the only FDA CBER head (maybe only FDA employee?) to be fired TWICE. Good riddance...
statnews.com/2025/11/04/fda-…
New: FDA's top drug regulator Tracy Beth Høeg is departing the agency following Marty Makary's exit earlier this week. CDER deputy director Mike Davis will serve as acting director bloomberg.com/news/articles/…
John Mason retweeted
Scientists under political pressure from Makary have shared their concerns through my office’s whistleblower channel. Here are a few:
"I was pressured into withholding a recommendation for approval for a drug that was intended for a rare disease by Dr. Prasad and other FDA leadership"...
"Direct lobbying to the Commissioner's office [is] a smart and productive business practice for companies to get what they want."
John Mason retweeted
Looks like @mercury raising new funding at a $5B+ val (lead investors selected but round size + exact val still TBD)
Last valued at $3.5B in Series C led by @sequoia ~1yr ago (Mar '25)
axios.com/pro/fintech-deals/…
More data on what fintech looks like at scale 📈
At the end of Q3, @mercury hit $650M in annualized revenue (monthly revenue, multiplied by 12), up from ~$500M at the end of 2024
Customer base is up 40% in 2025, and the company has been GAAP profitable on both net income + EBITDA for 3 consecutive yrs
Last valued at $3.5B in its Sequoia-led Series C earlier this year
John Mason retweeted
My meeting with Senator Johnson's office today went well! We are moving in the right direction. 💪💙
John Mason retweeted
here is link to release announcing new follow-up letter from rare disease coalition focused on restoring regulatory flexibility for rare disease under CBER. note letter and survey is from a coalition of over 140 rare disease leaders, not just rtw.
reuters.com/sustainability/b…
RTW open letter to FDA & HHS on their treatment of rare disease. @DrMakaryFDA - reduction in investment due to regulatory uncertainty creating worse outcomes for patients. @CNBC
John Mason retweeted
this is the first major mention i've seen of arnold venture's influence on this fda. arnold is said to be have been a major backer of prasad's research (i don't have proof of this, have just been told many times), and as wsj notes, szarama worked at arnold before prasad brought her in. most aren't aware arnold ventures was the major backer of ICER, the group that defines the value of medicines for the UK (which is set at a cap of roughly 30k pounds per human life year). it is also the reason the UK has dropped below basically all other developed countries when it comes to access to rare disease medicines. in short, arnold doesn't believe rare disease medicines are worth it, and it's natural to conclude prasad and others were bringing that philosophy to fda. now it's fine to have that view as a society (as the UK chooses to), but the trump administration represented the opposite, which is to accelerate access to rare disease medicines.
wsj.com/opinion/one-exit-won…
John Mason retweeted
Events in the Middle East and the Gulf region are unfolding extremely rapidly. Unfortunately, Ukraine knows all too well what this is about. Although Ukrainians never threatened Iran, the Iranian regime chose to become Putin’s accomplice and supplied him with “shahed” drones, and not only the drones themselves, but also the technologies to produce them. Iran also provided other weapons to Russia.
Over the course of this full-scale war, Russia has used more than 57,000 shahed-type attack drones against the Ukrainian people, cities, and energy infrastructure. Other nations have also suffered from Iranian-backed terror. Therefore, it is fair to give the Iranian people a chance to rid themselves of a terrorist regime and to guarantee security for all nations that have suffered from terror originating in Iran.
Our position is well known, and Ukraine has stated it repeatedly, including recently. It is important to preserve as many lives as possible. It is important to prevent the war from expanding. It is important that the United States is acting decisively. Whenever there is American resolve, global criminals weaken. This understanding must also come to the Russians.
People cannot know the day or the hour, yet every act of evil, terror, and aggression against neighbors ultimately meets a just response. We expect that, in the end, the Middle East region will become safer and more stable. Much has already changed toward that goal.
Ukraine is ready to help every nation so that security and justice increase, and terrorist regimes decrease.
Working on your testimonial for the upcoming hearing? Read Katie Jackson's full compelling statement regarding #FDA delays in relation to #HD on the Huntington's Post! #HopeOnHold
Full post: shorturl.at/wbkDB
Hearing Details: shorturl.at/h3Wgm
John Mason retweeted
Replying to @janeo1934
Why buy a stock that's going down? Just buy stocks that go up.































